James Wilson & Nasdaq-100
10 shared events · Importance 3 · Last updated May 09, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Business
James Wilson: James Wilson, a partner at Faruqi & Faruqi, is encouraging investors who suffered losses in Gossamer Bio to contact him to discuss their legal options.
Nasdaq-100: Gossamer Bio has not met the minimum share bid price required for continued listing on the Nasdaq Global Select Market, indicating a potential delisting.
Apr 01, 2026 · 103 articles
Business
James Wilson: James Wilson is a partner at Faruqi & Faruqi, encouraging investors who suffered losses in ODDITY Tech to contact him to discuss their legal rights.
Nasdaq-100: Nasdaq-100 is the stock exchange where ODDITY Tech securities are traded.
Apr 01, 2026 · 93 articles
Business
James Wilson: James Wilson, a partner at Faruqi & Faruqi, is encouraging investors who suffered losses in MiNK Therapeutics to contact him to discuss their legal rights.
Nasdaq-100: Nasdaq-100 is the stock exchange where MiNK Therapeutics' common stock is traded, providing the platform for the securities involved in the class action.
Apr 01, 2026 · 83 articles
Business
James Wilson: James Wilson, a partner at Faruqi & Faruqi, is encouraging investors who suffered losses in Gossamer Bio to contact him.
Nasdaq-100: Gossamer Bio's stock is traded on Nasdaq-100, and its price plummeted following the adverse study results.
May 01, 2026 · 6 articles
Business
James Wilson: James Wilson, a partner at Faruqi & Faruqi, is encouraging investors who suffered losses in Firefly Aerospace Inc. to contact him to discuss their legal options.
Nov 20, 2025 · 6 articles
Business
Nasdaq-100: Treace Medical Concepts is listed on Nasdaq-100, and its stock price fell significantly after the announcement of lowered revenue guidance.
May 16, 2025 · 6 articles
Business
Nasdaq-100: General Atomics, Inc. is listed on Nasdaq-100, and its stock price decline is noted in the context of the lawsuit.
May 14, 2025 · 6 articles
Regulatory
Nasdaq-100: Atara Biotherapeutics, Inc. is listed on Nasdaq-100, and its stock price decline is reported in relation to this exchange.
May 18, 2025 · 6 articles
NEWSDESK
Explore this relationship live
Track how James Wilson and Nasdaq-100 interact across events, view sentiment trends, and discover connected entities.
Open Dashboard